ENZND Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Enzon Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 5.11 USD -11.9% Market Closed

Market Cap: $379.2m

	Enzon Pharmaceuticals Inc OTC:ENZND	US
T	Tongcheng Travel Holdings Ltd SWB:TEM	CN
G	G3 Exploration Ltd F:G3J	CN
	Bank Permata Tbk PT F:BABB	ID
	Litalico Inc F:9N0	JP
	Red Rock Resorts Inc F:RRK	US
	NanoXplore Inc TSX:GRA	CA
M	Messaben Corp OTC:MSBN	CN

Profitability Summary

Enzon Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

10%

Low 3Y Average Gross Margin

Negative Operating Margin

-10%

Negative 3Y Average Operating Margin

-3 503%

Operating Margin is Increasing

-3 467% > -10%

Negative Net Margin

-13%

Negative 3Y Average Net Margin

-113%

Net Margin is Increasing

-1 933% > -13%

Negative Free Cash Flow Margin

-32%

Strong 3Y Average Free Cash Flow Margin

3 599%

Declining Free Cash Flow Margin

1 667% > -32%

Negative ROE

-9%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

311%

ROIC is Increasing

-706% > -5%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.